U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75%

Go back to U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75%

Intel (INTC) PT Lowered to $21 at Goldman Sachs, Cautious on PC Demand and Margins

October 17, 2024 12:49 PM EDT

Goldman Sachs analyst Toshiya Hari lowered the price target on Intel (NASDAQ: INTC) to $21.00 (from $22.00) while maintaining a Sell rating.

The analyst comments "Ahead of Intel's 3Q24 earnings release scheduled for 10/31 (post close), we reduce our 2025/26 non-GAAP EPS (excl. SBC)... More

Walgreens Boosts Alliance (WBA) PT Raised to $10 at Leerink Partners

October 16, 2024 6:53 AM EDT

Leerink Partners analyst Michael Cherny raised the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $10.00 (from $9.00) while maintaining a Market Perform rating.

The analyst comments "Bottom Line: With a fairly low bar and incredible negative sentiment, WBA's FY4Q'24 results/FY25 guide being less bad turned out to be a... More

Seaport Global Securities on Boeing (BA): 'We think investors continue buying'

October 16, 2024 6:52 AM EDT

Seaport Global Securities analyst Richard Safran reiterated a Buy rating and $207.00 price target on Boeing (NYSE: BA).

The analyst comments "Reiterate Buy after BA announced a $35B capital raise including a new $10B credit agreement and a registration covering up to $25B in... More

UnitedHealth Group (UNH) PT Lowered to $595 at RBC Capital

October 16, 2024 6:51 AM EDT

RBC Capital analyst Ben Hendrix lowered the price target on UnitedHealth Group (NYSE: UNH) to $595.00 (from $615.00) while maintaining a Outperform rating.

The analyst comments "We raise our 2025 MCR estimate by 70 bps and lower our adjusted EPS estimate to $29.75, which should approximate the... More

UnitedHealth Group (UNH) PT Lowered to $625 at Truist Securities

October 16, 2024 6:36 AM EDT

Truist Securities analyst David MacDonald lowered the price target on UnitedHealth Group (NYSE: UNH) to $625.00 (from $640.00) while maintaining a Buy rating.

The analyst comments "While UNH reported mixed 3Q results marked by a higher MLR, tightened 2024 guidance and provided a more conservative first glance at... More

BofA Securities Reiterates Underperform Rating on Walgreens Boosts Alliance (WBA)

October 16, 2024 6:24 AM EDT

BofA Securities analyst Allen Lutz reiterated an Underperform rating and $7.50 price target on Walgreens Boosts Alliance (NASDAQ: WBA)

The analyst comments "Walgreens is doing what it can to stabilize U.S. Retail Pharmacy profit. This includes closing stores, negotiating more aggressively with... More

Walgreens Boosts Alliance (WBA) PT Lowered to $10 at Deutsche Bank

October 16, 2024 6:18 AM EDT

Deutsche Bank analyst George Hill lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $10.00 (from $11.00) while maintaining a Hold rating.

The analyst comments "Initial 2025 Guide Could Prove to Be a Reach: WBA reported a modest FQ4 beat, and relatively weak F2025 guidance to relatively low expectations, which... More

UnitedHealth Group (UNH) PT Lowered to $595 at Deutsche Bank

October 16, 2024 6:17 AM EDT

Deutsche Bank analyst George Hill lowered the price target on UnitedHealth Group (NYSE: UNH) to $595.00 (from $632.00) while maintaining a Buy rating.

The analyst comments "Initial 2025 Outlook Comes Up Light: UNH reported F3Q results where the company first commented on its 2025 EPS outlook, with the initial guidance of ~ $30 in EPS being ~4% below the Streets ~$31.25 and the ~8% growth... More

Charles Schwab Corp. (SCHW) PT Raised to $84 at Jefferies

October 16, 2024 6:10 AM EDT

Jefferies analyst Daniel Fannon raised the price target on Charles Schwab Corp. (NYSE: SCHW) to $84.00 (from $73.00) while maintaining a Buy rating.

The analyst comments "Following 3Q24 results, our 4Q24 and 2025 EPS estimates adjust modesty to $0.87/$3.80 from $0.82/$3.85, respectively. The sharp rise in Sept... More

Goldman Sachs Reiterates Neutral Rating on Charles Schwab Corp. (SCHW)

October 16, 2024 6:05 AM EDT

Goldman Sachs analyst Alexander Blostein reiterated a Neutral rating and $74.00 price target on Charles Schwab Corp. (NYSE: SCHW).

The analyst comments "Following 3Q24 results, we adjust our estimates to reflect slightly higher sweep deposit balances in 3Q and the latest forward interest rates. September balances benefited from some seasonal... More

Charles Schwab Corp. (SCHW) PT Raised to $75 at Citi

October 16, 2024 5:54 AM EDT

Citi analyst Chris Allen raised the price target on Charles Schwab Corp. (NYSE: SCHW) to $75.00 (from $72.00) while maintaining a Neutral rating.

The analyst comments "SCHW finished up 6% yesterday following a top-line beat along with clear progress on paying down ST funding and growth of... More

Charles Schwab Corp. (SCHW) PT Raised to $74 at Barclays

October 16, 2024 5:45 AM EDT

Barclays analyst Benjamin Budish raised the price target on Charles Schwab Corp. (NYSE: SCHW) to $74.00 (from $64.00) while maintaining a Equalweight rating.

The analyst comments "Key takeaway: Revenues beat Street estimates by 1% driven by higher BDA and asset management fees while adj. opex was in line, and adj.... More